Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125227951 | 12522795 | 1 | I | 20120312 | 20160616 | 20160701 | 20160701 | EXP | BR20160396 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002198 | VALIDUS | 77.00 | YR | F | Y | 0.00000 | 20160701 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125227951 | 12522795 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, DAILY | Y | 16273 | 20 | MG | |||||||
125227951 | 12522795 | 2 | SS | COTAREG | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF, DAILY | Y | 0 | 1 | DF |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125227951 | 12522795 | 1 | Product used for unknown indication |
125227951 | 12522795 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125227951 | 12522795 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125227951 | 12522795 | Acute kidney injury | |
125227951 | 12522795 | Atrioventricular block complete | |
125227951 | 12522795 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125227951 | 12522795 | 1 | 20120312 | 0 | ||
125227951 | 12522795 | 2 | 20120312 | 0 |